"Reprogramming as an Approach to Neoplasms. " *
Jeannette A. Hovsepian 1, @ and John H. Frenster 2, @
Departments of 1 Radiology and of 2 Medicine, Stanford University School of Medicine, Stanford, California 94305, USA,
@ Present Addresses: RNA Research, Physicians’ Educational
Series, Atherton, CA 94027-5446 USA.
Phone: +1 650 367 6483; Fax: +1 650 364
1773; e-mail: frenster@euchromatin.net
* Supported in part by a USPHS Research Career Development Award (CA-17857) from the National Cancer Institute to J.H.F.
Although reprogramming of chromatin normally occurs during early telophase, activator RNA exchange can result in chromatin reprogramming during interphase (Frenster JH, and Hovsepian JA, "Activator RNA Exchange during Interphase Chromatin Reprogramming", RNA2004: 305 (2004). Small nuclear RNA species play a role in epigenetic silencing and/or activating of specific genes (Sleutels F, et al, "The Noncoding Air RNA is Required for Silencing Autosomal Imprinted Genes", Nature 415: 820 (2002), and may be necessary for mammalian cells in resisting oncogenic transformation (Takamizawa J, et al, "Reduced Expression of let-7 Micro RNAs in Human Lung Cancer is Associated with Shortened Post-Operative Survival," Cancer Res. 64: 3753 (2004). Many molecular lesions after transformation are DNA-based, including chromosomal amplification, deletion, mutation, and translocation. Epigenetic lesions, not involving DNA sequences directly, are RNA-based, and perhaps amenable to RNA exchange during reprogramming. An interesting experiment by DeCarvalho S., "Effect of RNA from Normal Human Marrow on Leukaemic Marrow In-Vivo", Nature 197: 1077 (1963) showed that pure isolated RNA from normal bone marrow was able to temporarily reverse the neoplastic state of human acute myelocytic leukemia cells following intra-marrow injection. RNA-based lesions may be more reversible than DNA-based lesions within human neoplasms. http://www.euchromatin.com/RepNeo01.htm .
Links to RNA and Biological Causality:
Links to
Euchromatin Activator RNA Reviews:
Links to
Euchromatin Activator RNA Research:
Links to Ultrastructural
Probes of DNase I-Sensitive Sites:
Links to
RNA as a Therapeutic Agent:
Links to Hodgkin Lymphoma
Immuno-Pathology:
Links to Activated
T-Lymphocyte Immunotherapy:
Links to Medical
Systems Biology:
Links to Selective
Gene Transcription:
Links to RNA-Induced
Epigenetics:
Links to RNA-Induced
Embryogenesis:
Links to RNA and
Biological Causality:
Links to Reprogramming
and Neoplasia:
A Brief History of Activator RNA:
"Ultrastructural Probes of Active DNA Sites, and the RNA Activators of DNA". (PowerPoint Presentation).